These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31905715)

  • 41. Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based nanoparticles.
    Leal AF; Cifuentes J; Torres CE; Suárez D; Quezada V; Gómez SC; Cruz JC; Reyes LH; Espejo-Mojica AJ; Alméciga-Díaz CJ
    Sci Rep; 2022 Sep; 12(1):15045. PubMed ID: 36057729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity.
    Fan JQ
    Biol Chem; 2008 Jan; 389(1):1-11. PubMed ID: 18095864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme replacement and enhancement therapies for lysosomal diseases.
    Desnick RJ
    J Inherit Metab Dis; 2004; 27(3):385-410. PubMed ID: 15190196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the biogenesis of heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase provides insights into the mechanism underlying its complete deficiency in mucopolysaccharidosis IIIC.
    Durand S; Feldhammer M; Bonneil E; Thibault P; Pshezhetsky AV
    J Biol Chem; 2010 Oct; 285(41):31233-42. PubMed ID: 20650889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of brain disease in the mucopolysaccharidoses.
    Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
    Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzyme replacement therapy for the mucopolysaccharide storage disorders.
    Kakkis ED
    Expert Opin Investig Drugs; 2002 May; 11(5):675-85. PubMed ID: 11996648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mucopolysaccharidoses: a success of molecular medicine.
    Clarke LA
    Expert Rev Mol Med; 2008 Jan; 10():e1. PubMed ID: 18201392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.
    Mohamed FE; Al-Gazali L; Al-Jasmi F; Ali BR
    Front Pharmacol; 2017; 8():448. PubMed ID: 28736525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The mucopolysaccaridoses: clinical and biochemical correlations.
    Horwitz AL
    Am J Ment Defic; 1979 Sep; 84(2):113-23. PubMed ID: 115315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
    Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
    Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis of Mucopolysaccharidoses, an Update.
    Fecarotta S; Tarallo A; Damiano C; Minopoli N; Parenti G
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.
    Rohrbach M; Clarke JT
    Drugs; 2007; 67(18):2697-716. PubMed ID: 18062719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses.
    Rintz E; Gaffke L; Podlacha M; Brokowska J; Cyske Z; Węgrzyn G; Pierzynowska K
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase.
    Tomatsu S; Gutierrez M; Nishioka T; Yamada M; Yamada M; Tosaka Y; Grubb JH; Montaño AM; Vieira MB; Trandafirescu GG; Peña OM; Yamaguchi S; Orii KO; Orii T; Noguchi A; Laybauer L
    Hum Mol Genet; 2005 Nov; 14(22):3321-35. PubMed ID: 16219627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases.
    Oh DB
    BMB Rep; 2015 Aug; 48(8):438-44. PubMed ID: 25999178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
    Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses.
    Wegrzyn G; Wegrzyn A; Tylki-Szymańska A
    Med Hypotheses; 2004; 62(6):986-92. PubMed ID: 15142662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders.
    Parker EI; Xing M; Moreno-De-Luca A; Harmouche E; Terk MR
    Br J Radiol; 2014 Jan; 87(1033):20130467. PubMed ID: 24234586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses.
    De Pasquale V; Pavone LM
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165539. PubMed ID: 31465828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.